Infusion Pump Market Size by 2026

An infusion pump is a medical device that delivers fluids, including medications, nutrients, and blood products, into a patient's body in a controlled and precise manner. The infusion pump market includes a variety of devices that are used in various settings such as hospitals, clinics, and homecare.

The global infusion pump market is driven by factors such as the increasing prevalence of chronic diseases, the aging population, and the rising demand for ambulatory infusion pumps. Technological advancements such as the development of smart infusion pumps with advanced features such as wireless connectivity, mobile applications, and cloud-based data storage have also contributed to the growth of the market.

The market is segmented by product type, application, end-user, and region. Product types include volumetric pumps, syringe pumps, ambulatory pumps, enteral pumps, insulin pumps, and patient-controlled analgesia pumps. Applications include chemotherapy, diabetes, gastrointestinal diseases, pediatrics, and others. End-users include hospitals, ambulatory surgical centers, homecare settings, and others.

North America dominates the global infusion pump market due to the presence of well-established healthcare infrastructure, increasing healthcare expenditure, and high adoption of advanced technologies. However, the Asia Pacific region is expected to grow at a faster rate due to the rising prevalence of chronic diseases and increasing healthcare spending.

What is the outlook for Infusion Pump Market?

The outlook for the infusion pump market is positive, with growth expected to continue in the coming years. The market is driven by several factors, including the increasing prevalence of chronic diseases, the aging population, and the rising demand for ambulatory infusion pumps.

According to a report by Market Research Engine, the global infusion pump market is expected to grow from $13.5 billion in 2020 to $18.9 billion by 2025, at a CAGR of 7.0% during the forecast period. The report attributes this growth to the increasing prevalence of chronic diseases, the growing geriatric population, and the rising demand for ambulatory infusion pumps.

In addition, the development of smart infusion pumps with advanced features such as wireless connectivity, mobile applications, and cloud-based data storage is expected to drive the growth of the market. The Asia Pacific region is expected to witness the highest growth rate during the forecast period, due to the increasing prevalence of chronic diseases, rising healthcare spending, and increasing adoption of advanced technologies.

Overall, the infusion pump market is expected to continue to grow, driven by factors such as increasing demand for homecare settings and the development of advanced technologies that improve patient outcomes and reduce the risk of medication errors.

How Big is the Infusion Pump Market?

As of 2021, the global infusion pump market size was valued at approximately USD 12.3 billion and is projected to reach USD 21.5 billion by 2028, growing at a compound annual growth rate (CAGR) of around 7.2% during the forecast period (2021-2028).

Factors driving the growth of the infusion pump market include an increase in the prevalence of chronic diseases, a rise in the geriatric population, the growing demand for home healthcare services, and technological advancements in infusion pumps.

North America holds the largest market share, followed by Europe and Asia-Pacific. The major players in the infusion pump market include B. Braun Melsungen AG, Baxter International Inc., Fresenius Kabi AG, ICU Medical, Inc., Medtronic plc, Smiths Medical, and Terumo Corporation, among others.

Infusion Pump  Market Size, Share, Analysis

The global infusion pump market size was valued at USD 11.87 billion in 2021 and is projected to reach USD 18.81 billion by 2028, growing at a CAGR of 6.7% during the forecast period.

Infusion pumps are medical devices used to deliver fluids, including medication, nutrition, and blood, to patients in a controlled manner. The increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, is driving the demand for infusion pumps. In addition, the rising geriatric population, increasing demand for home healthcare services, and advancements in technology are further propelling market growth.

By product type, the volumetric infusion pumps segment held the largest market share in 2021, owing to its ability to deliver precise volumes of fluids and medications over a specific period. By application, the chemotherapy segment held the largest market share in 2021, owing to the increasing prevalence of cancer and the rising demand for chemotherapy treatments.

Geographically, North America dominated the infusion pump market in 2021, owing to the increasing incidence of chronic diseases, favorable reimbursement policies, and a well-established healthcare infrastructure. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period, owing to the increasing demand for healthcare services, rising geriatric population, and increasing investments in the healthcare sector.

Key players operating in the infusion pump market include B. Braun Melsungen AG, Baxter International Inc., Fresenius Kabi AG, ICU Medical Inc., Medtronic plc, Smiths Medical, Terumo Corporation, Nipro Corporation, and Johnson & Johnson Services, Inc. These companies are focusing on expanding their product portfolios, collaborating with other companies, and investing in research and development to maintain their market position.

Browse further details of this market:  https://www.marketresearchengine.com/infusion-pump-market-size